Rene Labatut
Microbiology and immunology
Sanofi
France
Biography
Rene Labatut has experience in CMC Management in Biopharmaceutical Industry from research and development to manufacturing in highly regulated environment (US, EU, Japan, China etc). He has developed a worldwide international skill set in innovation, technology transfer, licensing in and out and acquisition integration management. He is the Vice President of Manufacturing Technology of Sanofi Pasteur; the vaccines division of Sanofi. He has delivered numerous speeches in reputed conferences and has been serving as a steering Committee Member of Center for Biomedical Innovation at MIT. He has brought significant contribution to several key healthcare product developments like ceredase, thymoglobulin, hexavalent pediatric, flu and dengue vaccines. He holds PhD in Biochemistry, Master in Bioengineering from National Institute of Applied Sciences, Master in Molecular Biology from Lyon I University and Master in Business from Lyon III University Rene Labatut has experience in CMC Management in Biopharmaceutical Industry from research and development to manufacturing in highly regulated environment (US, EU, Japan, China etc). He has developed a worldwide international skill set in innovation, technology transfer, licensing in and out and acquisition integration management. He is the Vice President of Manufacturing Technology of Sanofi Pasteur; the vaccines division of Sanofi. He has delivered numerous speeches in reputed conferences and has been serving as a steering Committee Member of Center for Biomedical Innovation at MIT. He has brought significant contribution to several key healthcare product developments like ceredase, thymoglobulin, hexavalent pediatric, flu and dengue vaccines. He holds PhD in Biochemistry, Master in Bioengineering from National Institute of Applied Sciences, Master in Molecular Biology from Lyon I University and Master in Business from Lyon III University
Research Interest
Vaccines and Immunology